title: What is the role of lipoprotein abnormalities and platelet aggregation defects in cardiovascular disease in chronic dialysis patients?
authors.affiliation: Institute of Hypertension and Kidney Diseases, Rabin Medical Center, Petah Tikva, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Winkler
authors.forename: G
authors.initials: G
authors.lastname: Boner
authors.forename: D
authors.initials: D
authors.lastname: Gavish
authors.forename: J
authors.initials: J
authors.lastname: Fuchs
authors.forename: I
authors.initials: I
authors.lastname: Weinberger
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D010974:Platelet Aggregation; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D008074:Lipoproteins